Heifets L B, Iseman M D
Am Rev Respir Dis. 1985 Sep;132(3):710-1. doi: 10.1164/arrd.1985.132.3.710.
The in vitro susceptibility of different mycobacterial species to ansamycin (LM427) in concentrations of 2.0, 1.0, 0.5, and 0.2 micrograms/ml was determined by the agar dilution method. For those strains of M. tuberculosis and M. avium complex tested, susceptibility to ansamycin was compared with susceptibility to rifampin. All M. tuberculosis strains susceptible to rifampin were susceptible to ansamycin; the strains that were highly resistant to rifampin also were resistant to ansamycin. The majority of M. avium complex strains were "naturally" resistant to rifampin (1.0 micrograms/ml and higher), but only approximately 13% of them were resistant to ansamycin in a concentration of 1.0 microgram/ml. The cross-resistance in M. avium strains was made apparent only by comparing patterns of resistance to low concentrations of ansamycin (0.5 microgram/ml) with patterns of resistance to higher concentrations of rifampin (5.0 and 10.0 micrograms/ml).
采用琼脂稀释法测定了不同分枝杆菌菌种对浓度为2.0、1.0、0.5和0.2微克/毫升的安莎霉素(LM427)的体外敏感性。对于所检测的结核分枝杆菌和鸟分枝杆菌复合群菌株,将其对安莎霉素的敏感性与对利福平的敏感性进行了比较。所有对利福平敏感的结核分枝杆菌菌株对安莎霉素也敏感;对利福平高度耐药的菌株对安莎霉素也耐药。大多数鸟分枝杆菌复合群菌株对利福平(1.0微克/毫升及更高浓度)“天然”耐药,但其中只有约13%的菌株对浓度为1.0微克/毫升的安莎霉素耐药。只有通过比较对低浓度安莎霉素(0.5微克/毫升)的耐药模式与对高浓度利福平(5.0和10.0微克/毫升)的耐药模式,鸟分枝杆菌菌株中的交叉耐药性才变得明显。